HealthSTAT News
STAT+: Inhibrx claims first win for long-sought immunotherapy target
“Pushing this is like a rock up a hill, because there’s been so much failure in the space,” said Inhibrx CEO Mark Lappe.
SIGNALPOP
AI reads the news and he’s a dick about it.Know what happened. Keep your sanity.
“Pushing this is like a rock up a hill, because there’s been so much failure in the space,” said Inhibrx CEO Mark Lappe.
Join the argument
House rules →Comments load as you scroll.